Home LiteratureArticle Details
PMID: 21132010 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

GNL3L depletion destabilizes MDM2 and induces p53-dependent G2/M arrest.

Oncogene ·Vol. 30 ·No. 14 ·2011-04-07 ·Pages 1716-26

Meng L, Hsu JK, Tsai RY

Abstract

Guanine nucleotide binding protein-like 3-like (GNL3L) is a nucleolar protein and the vertebrate paralogue of nucleostemin (NS). We previously reported that nucleoplasmic mobilization of NS stabilizes MDM2 (mouse double minute 2). Here, we investigated the role of GNL3L as a novel MDM2 regulator. We found that GNL3L binds MDM2 in vivo and displays the same function as NS in stabilizing MDM2 protein and preventing its ubiquitylation. The interaction between GNL3L and MDM2 also takes place in the nucleoplasm. However, the MDM2 regulatory activity of GNL3L occurs constitutively and does not so much depend on the nucleolar release mechanism as NS does. GNL3L depletion triggers G2/M arrest in the p53-wild-type HCT116 cells more than in the p53-null cells, and upregulates specific p53 targets (that is, Bax, 14-3-3σ and p21) without affecting the ubiquitylation or stability of p53 proteins. The inhibitory activity of GNL3L on p53-mediated transcription correlates with the increased expression of GNL3L and reduced expression of 14-3-3σ and p21 in human gastrointestinal tumors. This work shows that in contrast to most nucleolar proteins that negatively control MDM2, GNL3L and NS are the only two that are designed to stabilize MDM2 protein under basal or induced condition, respectively, and may act as tumor-promoting genes.

MeSH Terms
14-3-3 Proteins/biosynthesis Biomarkers, Tumor/biosynthesis Carcinoma/metabolism Cell Cycle/drug effects Cell Division Cyclin-Dependent Kinase Inhibitor p21/biosynthesis Exonucleases/biosynthesis Exoribonucleases G2 Phase GTP-Binding Proteins/genetics,metabolism Gastrointestinal Neoplasms/metabolism HCT116 Cells Humans Nuclear Proteins/genetics,metabolism Proto-Oncogene Proteins c-mdm2/metabolism Tumor Suppressor Protein p53/metabolism Ubiquitination/drug effects Up-Regulation bcl-2-Associated X Protein/biosynthesis
Chemicals
14-3-3 Proteins Biomarkers, Tumor CDKN1A protein, human Cyclin-Dependent Kinase Inhibitor p21 GNL3L protein, human Nuclear Proteins Tumor Suppressor Protein p53 bcl-2-Associated X Protein MDM2 protein, human Proto-Oncogene Proteins c-mdm2 Exonucleases Exoribonucleases SFN protein, human GTP-Binding Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Meng L
Center for Cancer and Stem Cell Biology, Alkek Institute of Biosciences and Technology, Texas A and M Health Science Center, Houston, TX 77030, USA.
Hsu J K
Tsai R Y L
References (30)
30 references, click to expand
  1. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Mol Cell. 2006 Jul 21;23(2):251-63 PMID: 16857591
  2. Aberrant expression of nucleostemin activates p53 and induces cell cycle arrest via inhibition of MDM2.
    Mol Cell Biol. 2008 Jul;28(13):4365-76 PMID: 18426907
  3. Multiple controls regulate nucleostemin partitioning between nucleolus and nucleoplasm.
    J Cell Sci. 2006 Dec 15;119(Pt 24):5124-36 PMID: 17158916
  4. Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
    Mol Cell Biol. 2004 Sep;24(17):7669-80 PMID: 15314174
  5. Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
    Science. 1998 Nov 20;282(5393):1497-501 PMID: 9822382
  6. Differential effects of Nucleostemin suppression on cell cycle arrest and apoptosis in the bladder cancer cell lines 5637 and SW1710.
    Cell Prolif. 2009 Dec;42(6):762-9 PMID: 19706044
  7. Nucleolar trafficking of nucleostemin family proteins: common versus protein-specific mechanisms.
    Mol Cell Biol. 2007 Dec;27(24):8670-82 PMID: 17923687
  8. Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway.
    Mol Cell Biol. 2003 Dec;23(23):8902-12 PMID: 14612427
  9. 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.
    Mol Cell. 1997 Dec;1(1):3-11 PMID: 9659898
  10. Nucleostemin delays cellular senescence and negatively regulates TRF1 protein stability.
    Mol Cell Biol. 2006 Dec;26(24):9279-90 PMID: 17000763
  11. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection.
    J Cell Biochem. 2003 Aug 15;89(6):1235-49 PMID: 12898521
  12. Identification of stem cells during prepubertal spermatogenesis via monitoring of nucleostemin promoter activity.
    Stem Cells. 2008 Dec;26(12):3237-46 PMID: 18802033
  13. Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.
    J Biol Chem. 2000 Mar 24;275(12):8945-51 PMID: 10722742
  14. Depletion of guanine nucleotides leads to the Mdm2-dependent proteasomal degradation of nucleostemin.
    Cancer Res. 2009 Apr 1;69(7):3004-12 PMID: 19318567
  15. GNL3L stabilizes the TRF1 complex and promotes mitotic transition.
    J Cell Biol. 2009 Jun 1;185(5):827-39 PMID: 19487455
  16. Nucleostemin: a latecomer with new tricks.
    Int J Biochem Cell Biol. 2009 Nov;41(11):2122-4 PMID: 19501670
  17. Nucleoplasmic mobilization of nucleostemin stabilizes MDM2 and promotes G2-M progression and cell survival.
    J Cell Sci. 2008 Dec 15;121(Pt 24):4037-46 PMID: 19033382
  18. GNL3L inhibits activity of estrogen-related receptor gamma by competing for coactivator binding.
    J Cell Sci. 2007 Aug 1;120(Pt 15):2532-43 PMID: 17623774
  19. Analysis of the degradation function of Mdm2.
    Cell Growth Differ. 1999 Feb;10(2):87-92 PMID: 10074902
  20. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation.
    Cancer Cell. 2004 May;5(5):465-75 PMID: 15144954
  21. Purification of human telomerase complexes identifies factors involved in telomerase biogenesis and telomere length regulation.
    Mol Cell. 2007 Dec 14;28(5):773-85 PMID: 18082603
  22. Evolutionarily conserved role of nucleostemin: controlling proliferation of stem/progenitor cells during early vertebrate development.
    Mol Cell Biol. 2006 Dec;26(24):9291-301 PMID: 17000755
  23. Regulation of the G2/M transition by p53.
    Oncogene. 2001 Apr 5;20(15):1803-15 PMID: 11313928
  24. Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway.
    Mol Biol Cell. 2007 Jul;18(7):2630-5 PMID: 17494866
  25. Myocardial induction of nucleostemin in response to postnatal growth and pathological challenge.
    Circ Res. 2008 Jul 3;103(1):89-97 PMID: 18519946
  26. Rapid accumulation of nucleostemin in nucleolus during newt regeneration.
    Dev Dyn. 2007 Apr;236(4):941-50 PMID: 17133523
  27. Ribosomal protein L23 activates p53 by inhibiting MDM2 function in response to ribosomal perturbation but not to translation inhibition.
    Mol Cell Biol. 2004 Sep;24(17):7654-68 PMID: 15314173
  28. In search of nonribosomal nucleolar protein function and regulation.
    J Cell Biol. 2009 Mar 23;184(6):771-6 PMID: 19289796
  29. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells.
    Genes Dev. 2002 Dec 1;16(23):2991-3003 PMID: 12464630
  30. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6937-41 PMID: 10359817
Article Info
Journal
Oncogene
Abbr.
Oncogene
ISSN
1476-5594
Published
2011-04-07
Epub
2010-00-06
Pages
1716-26
Language
English
Region
England
NLM ID
8711562
PMCID
PMC3072457
Subset
IM
Grants
NCI NIH HHS · R01 CA113750 · United States
NCI NIH HHS · R01 CA113750-05 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com